Scynexis (SCYX) Notes Payables (2018)

Scynexis' (SCYX) quarterly Notes Payables came in at $174000.0 in Q3 2018, down 94.6% quarter-over-quarter from $3.2 million in Q2 2018.

Analysis

Scynexis (SCYX) Notes Payables (2018) Analysis & Trends

Scynexis (SCYX) has reported Notes Payables for 1 consecutive years, with $174000.0 the latest figure, recorded in Q3 2018.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Amgen	211.73 Bn	197.74 Bn	7.24 Bn
2	Gilead Sciences	180.92 Bn	177.74 Bn	6.22 Bn
3	Vertex Pharmaceuticals	132.16 Bn	124.30 Bn	2.84 Bn
4	Regeneron Pharmaceuticals	82.89 Bn	74.90 Bn	3.93 Bn
5	Argenx Se	61.41 Bn	56.23 Bn	1.37 Bn
6	Moderna	53.99 Bn	48.85 Bn	52.00 Mn
7	Alnylam Pharmaceuticals	34.48 Bn	31.18 Bn	992.69 Mn
8	Biogen	31.15 Bn	29.86 Bn	1.96 Bn
9	Roivant Sciences	30.05 Bn	30.05 Bn	1.16 Mn
10	Scynexis	58.41 Mn	-56.29 Mn	-

Historic Data

Download Data